Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:    
Net loss $ (16,673) $ (27,360)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 4,082 4,072
Noncash interest expense 555 400
Depreciation expense 17 11
Asset impairment 723 0
Change in fair value of short-term investment 293 0
Changes in operating assets and liabilities:    
Prepaid, other current assets and other short-term investment (31) 114
Interest payable (84) (3)
Accounts payable and accrued expenses (1,366) 252
End of term charge associated with Hercules Note (398) 0
Other 75 0
Net cash used in operating activities (12,807) (22,514)
Cash flows from investing activities:    
Purchase of property and equipment 0 (187)
Purchase of investments, short-term (345) 0
Purchase of investment, long-term (250) 0
Net cash used in investing activities (595) (187)
Cash flows from financing activities:    
Proceeds from issuance of Common Stock 606 90,629
Payment of costs related to the issuance of Common Stock (32) (1,860)
Payment of Hercules Note (13,655) 0
Proceeds from IDB Note 14,009 0
Payment of debt issue costs associated with IDB Note (9) 0
Transfer of restricted cash (15,446) 0
Net cash (used in)/provided by financing activities (14,527) 88,769
(Decrease)/Increase in cash and cash equivalents (27,929) 66,068
Cash and cash equivalents—beginning of period 99,521 40,199
Cash and cash equivalents—end of period 71,592 106,267
Supplemental disclosure of cash flow information:    
Cash paid for interest 614 1,052
Supplemental disclosure of non-cash financing and investing activities:    
Issuance of Restricted Stock $ 4 $ 0